2 terminated, 2 unknown, 1 active not recruiting, 1 completed. 6 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Terminated 2, Unknown 2, Active not recruiting 1, Completed 1 |
| Phase 3 | 2 | Active not recruiting 1, Completed 1 |
Follow Overactive Bladder Syndrome: new trials by email Literature Review of Overactive Bladder Syndrome trials Research Report on Overactive Bladder Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing MitoQ on Lower Urinary Tract Symptoms in Older Women With Metabolic Syndrome MitoQ (mitoquinol mesylate), Placebo - Lower Urinary Tract Symptoms, Overactive Bladder Syndrome | Phase 2 | Terminated | Iman Al-Naggar, PhD | 20 | 2024-04-03 | 2026-05-01 |
| Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms OnabotulinumtoxinA - Urinary Incontinence, Overactive Bladder Syndrome | Phase 2 / Phase 3 | Active not recruiting | Northwestern University | 66 | 2023-07-13 | 2026-11-06 |
| Xeomin vs Botox for Treatment of Overactive Bladder Syndrome Xeomin 100 UNT Injection, Botox 100 UNT Injection - Overactive Bladder Syndrome | Phase 2 | Unknown | Walter Reed National Military Medical Center | 64 | 2023-05-04 | 2023-10-13 |
| Comparison of Solifenacin and Mirabegron in Treatment of Overactive Bladder Symptoms in Men After TURP Solifenacin 5Mg, Mirabegron 50 MG - Overactive Bladder Syndrome | Phase 2 | Unknown | Buddhist Tzu Chi General Hospital | 130 | 2018-08-01 | 2018-08-24 |
| Herbal Patch for Overactive Bladder herbal patch, placebo patch - Overactive Bladder Syndrome | Phase 2 / Phase 3 | Completed | En Chu Kong Hospital | 66 | 2018-05-14 | 2019-10-25 |
| Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity AV608 - Overactive Bladder Syndrome | Phase 2 | Terminated | Avera Pharmaceuticals | 62 | 2006-06-01 | 2008-02-25 |
Urinary Bladder, Overactive (3) · Lower Urinary Tract Symptoms (1) · Metabolic Syndrome (1) · Urinary Incontinence (1) · Urinary Incontinence, Urge (1) · Urologic Diseases (1)
Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Urological Manifestations (4) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Lower Urinary Tract Symptoms (3) · Male Urogenital Diseases (3) · Urinary Bladder Diseases (3) · Urogenital Diseases (3) · Urination Disorders (2) · Urologic Diseases (2) · Glucose Metabolism Disorders (1) · Hyperinsulinism (1) · Insulin Resistance (1) · Metabolic Diseases (1)
Botulinum Toxins, Type A (2) · Solifenacin Succinate (1) · incobotulinumtoxinA (1) · mirabegron (1) · mitoquinone (1)
Avera Pharmaceuticals (1) · Buddhist Tzu Chi General Hospital (1) · En Chu Kong Hospital (1) · Iman Al-Naggar, PhD (1) · Northwestern University (1) · Walter Reed National Military Medical Center (1)
United States (3) · Taiwan (2) · Netherlands (1) · United Kingdom (1)
Amy Krambeck, MD (1) · Anna S Trikhacheva, MD (1) · Hann-Chorng Kuo, M.D. (1) · Iman M Al-Naggar, PhD (1) · Joao Siffert, MD (1) · Linda Cardozo, MD FRCOG (1)
P30AG067988 (1)